Peter Graham

发表

What happens to testosterone after prostate radiation monotherapy, and does it matter

T. Pickles, Peter Graham, 2001 .

The effect of adjuvant postmastectomy radiotherapy bolus technique on local recurrence.

M. T. Tieu, Y. Chin, L. Browne, 2011, International journal of radiation oncology, biology, physics.

Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial.

R. Fisher, H. Mameghan, J. Kearsley, 2004, International journal of radiation oncology, biology, physics.

Re Panoff et al., Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation

Peter Graham, 2011, Breast Cancer Research and Treatment.

Women’s choice between sentinel lymph node biopsy and axillary clearance

G. Papadatos, C. Magarey, Peter Graham, 2002, ANZ journal of surgery.

Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression

Yong Li, J. Beretov, Xupeng Bai, 2019, BMC Cancer.

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.

D. Goldstein, B. Iacopetta, A. Kneebone, 2008, International journal of radiation oncology, biology, physics.

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

W. Duan, Yong Li, J. Bucci, 2018, BMC Cancer.

Breast conservation for ductal carcinoma in situ: Results at an Australian institution with evidence to recommend prospective assessment of the utility of a lumpectomy boost

Y. Chin, L. Browne, Peter Graham, 2008 .

p27KIP‐1 cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27KIP‐1 correlates with hormone receptor status but not with local recurrence

E. Millar, P. Graham, P. Marr, 2007, Pathology international.

The RABBIT risk-based approach to clinical implementation of new technology: SRS as a case study

Johnson Yuen, Anna Ralston, Peter Graham, 2020, Technical innovations & patient support in radiation oncology.

MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer.

A. Harris, S. O'toole, C. Selinger, 2015, International journal of radiation oncology, biology, physics.

Communicating breast cancer treatment complication risks: When words are likely to fail

P. Graham, L. Browne, Rowena Martin, 2009 .

Metastatic cutaneous squamous cell carcinoma to parotid nodes: The role of bolus with adjuvant radiotherapy

P. Graham, L. Browne, A. Pramana, 2012, Journal of medical imaging and radiation oncology.

Reliability of the BCCT.core software in evaluation of breast cosmesis – A systematic review

R. Fernandez, H. Lord, Peter Graham, 2021, Journal of medical imaging and radiation oncology.

Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance

Yong Li, J. Beretov, Xupeng Bai, 2021, Journal of the National Cancer Center.

Radical radiotherapy for early nonsmall cell lung cancer.

V. Gebski, P. Graham, A. Langlands, 1995, International journal of radiation oncology, biology, physics.

Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance

Yong Li, J. Kearsley, J. Bucci, 2013, Cell Death and Disease.

Concurrent end-phase boost high-dose radiation therapy for non-small-cell lung cancer with or without cisplatin chemotherapy.

M. Links, C. Fox, P. Clingan, 2006, Australasian radiology.

(Sub)Section: All Author(s): CLAs: Oswaldo Lucon, Diana Urge Vorsatz LAs: Azni Zain Ahmed, Hashem Akbari, Paolo Bertoldi, Luisa Cabeza, Nicholas

L. D. Danny Harvey, M. V. Vilariño, C. Pyke, 2012 .